(Q36236341)

12 August 2017

Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide (English)

1 reference

12 August 2017

0 references

1 reference

0 references

11

Susan Swindells

1 reference

12 August 2017

1

Jacques Grosset

1 reference

12 August 2017

12

William R Bishai

1 reference

12 August 2017

Deepak Almeida

2

1 reference

12 August 2017

Paul J Converse

3

1 reference

12 August 2017

Sandeep Tyagi

4

1 reference

12 August 2017

Si-Yang Li

5

1 reference

12 August 2017

Nicole C Ammerman

6

1 reference

12 August 2017

Alexander S Pym

7

1 reference

12 August 2017

Kristina Wallengren

8

1 reference

12 August 2017

Richard Hafner

9

1 reference

12 August 2017

Umesh Lalloo

10

1 reference

12 August 2017

language of work or name

English

0 references

publication date

27 August 2012

1 reference

Proceedings of the National Academy of Sciences of the United States of America

12 August 2017

1 reference

12 August 2017

109

1 reference

12 August 2017

37

1 reference

12 August 2017

15001-15005

1 reference

14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Paradoxical effect of isoniazid on the activity of rifampin-pyrazinamide combination in a mouse model of tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

The early bactericidal activity of anti-tuberculosis drugs: a literature review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Moxifloxacin-containing Regimen Greatly Reduces Time to Culture Conversion in Murine Tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

The curious characteristics of pyrazinamide: a review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Preventive chemotherapy of tuberculosis in Cornell model mice with combinations of rifampin, isoniazid, and pyrazinamide

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Antagonism between isoniazid and the combination pyrazinamide-rifampin against tuberculosis infection in mice

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Bioavailability of rifampin in experimental murine tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

The early bactericidal activity of drugs in patients with pulmonary tuberculosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days

29 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1203636109

Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.1203636109

Cough frequency and infectivity in patients with pulmonary tuberculosis

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3443175

The eradication of tuberculosis: Theoretical problems and practical solutions

22 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22927424

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22927424

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1203636109

1 reference

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

22927424

1 reference